Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
批准号:
10707293
负责人:
STEVEN C. SCHACHTER
金额:
$21.15万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-06-30
关键词:
AddressAdvocateAreaCaregiversCollaborationsCommunicationCommunitiesDevelopmentDiagnosisEducationElectronic MailEvaluationFaceFocus GroupsFundingIncubatorsIndustryInterdisciplinary StudyLeadershipLearningMentorsMethodsNeeds AssessmentOutcomePatientsPerformancePress ReleasesProcessProfessional OrganizationsPublicationsResearchRiskServicesSpecific qualifier valueTechnologyTrainingTranslational ResearchUnited States National Institutes of HealthVoicecommercializationequity, diversity, and inclusionexperienceinnovationinterestmeetingsnervous system disordernewsoutreachprogramsresearch data disseminationsocial mediasuccesstoolweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract - OUTREACH CORE
The Outreach Core will be the public face and communications center for CINTA. Under the direction of the
CINTA Coordination Team and the Steering Committee, and with logistical support from the Administrative
Core, the Outreach Core is responsible for broad outreach to a diverse community of stakeholders using a
variety of methods including needs assessments, solicitation announcements, news and education, research
dissemination, and collaboration with the other funded hubs. Capturing and amplifying the voices of patients,
caregivers, and diverse, underrepresented communities will be a central guiding principle. CIMIT has decades
of experience in translational research and multidisciplinary collaboration. Since its founding in 1998, CIMIT
has supported nearly 800 innovative projects, including annual needs assessments, issuance of solicitations,
customized innovator support, and targeted dissemination of relevant information. The proposed CINTA
Outreach Core will build upon the experience and lessons learned from supporting these NIH programs and
will add further process innovations. CINTA will conduct annual needs assessments and stakeholder outreach
to support the areas of interests of the NIH Participating Organizations. Strategies for conducting annual needs
assessments will be based on input from the Steering Committee and Consumer Advisory Board. These
panels have been constituted to broadly reflect the areas of emphasis of the NIH Participating Organizations.
CINTA will use methods that CIMIT has employed in past years and will also broadly engage stakeholders by
use of social media and Zoom focus groups for identifying unmet needs for disorders of the nervous system.
These sessions will include the perspectives of patient advocates, nonprofit and philanthropic organizations,
professional societies, the academic research community, industry, payers, and others. Results of annual
needs assessments will be presented to CINTA leadership to develop appropriate criteria for performance
specifications where technology-based solutions would have the highest impact to address identified unmet
needs. Specifications will be included in the solicitation and will be used as review criteria by the Evaluation
Core. The Outreach Core will augment efforts by Mentor Teams, consultants, and subject matter experts to
train funded teams, including conducting an “Investor Forum” to connect subproject teams with potential
investors. CINTA will collaborate with other hubs to plan annual meetings and publications for sharing
outcomes and lessons learned. CINTA will facilitate communications among funded hubs and internal
dissemination of outcomes and lessons learned. If desired, CINTA will be pleased to construct and maintain a
Blueprint MedTech: Incubator Hubs program-specific website to be shared among the other hubs. Creating a
public narrative for both the Blueprint MedTech: Incubator Hubs program and for awardees is critical to
success. Press releases for program launch can be developed and disseminated through email, social media,
and, optionally, via a press wire service or press list.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
-
批准号:10707297
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
-
批准号:10516345
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
-
批准号:10707291
-
项目类别:
-
资助金额:$245.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
-
批准号:10516346
-
项目类别:
-
资助金额:$20.34万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
-
批准号:10516347
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
FEASIBILITY OF A COMBINED SEIZURE DETECTOR-VNS SYSTEM
-
批准号:7718938
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2008
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
-
批准号:6118949
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
-
批准号:6265420
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF GP47779 (NHD OF OXCARBAZEPINE) ADMINISTERED IV TO INPATIENTS
-
批准号:6265423
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EXTENSION TRIAL OF OXCARBAZEPINE IN PATIENTS W/ PARTIAL SEIZURES
-
批准号:6265424
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
PREGABALIN OPEN LABEL, FOLLOW ON SAFETY TRIAL IN PATIENTS W/ EPILEPSY
-
批准号:6265422
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
PREGABALIN IN PATIENT MONOTHERAPY TRIAL IN PATIENTS W/ EPILEPSY
-
批准号:6265421
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
VAGUS NERVE STIMULATION FOR ADJUNCTIVE TREATMENT OF EPILEPSY
-
批准号:6250105
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE AS MONOTHERAPY FOR COMPLEX PARTIAL SEIZURES
-
批准号:2637100
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF OXCARBAZEPINE IN PATIENTS WITH PARTIAL SEIZURES
-
批准号:6279904
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
-
批准号:6279969
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF OXCARBAZEPINE IN PATIENTS WITH PARTIAL SEIZURES
-
批准号:6250075
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE IN TREATMENT OF COMPLEX CHILDRENS HOSPITAL
-
批准号:2741400
-
项目类别:
-
资助金额:$13.85万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
REMACEMIDE INPATIENT SEIZURE EVALUATION TRIAL
-
批准号:6250146
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE IN TREATMENT OF COMPLEX CHILDRENS HOSPITAL
-
批准号:2879956
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
海外基金